Asensus Surgical
(NYSEMKT) ASXC
Asensus Surgical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$9.85M
Net Income (TTM)
$83.80M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ASXC News
ASXC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Asensus Surgical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
209
CEO
Anthony Fernando, MBA
Website
www.asensus.comHeadquarters
Durham, NC 27703, US
ASXC Financials
Key Financial Metrics (TTM)
Gross Margin
-53%
Operating Margin
-9%
Net Income Margin
-9%
Return on Equity
-1%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$4.58M
Operating Income
$79.47M
EBITDA
$74.40M
Operating Cash Flow
$63.63M
Capital Expenditure
$561.00K
Free Cash Flow
$64.19M
Cash & ST Invst.
$21.07M
Total Debt
$5.68M
Asensus Surgical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.21M
+104.2%
Gross Profit
$562.00K
+71.8%
Gross Margin
-25.46%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
207
N/A
Net Income
$25.75M
-24.6%
EBITDA
$24.40M
-23.7%
Quarterly Fundamentals
Net Cash
$13.72M
-139.8%
Accounts Receivable
$406.00K
-38.5%
Inventory
$7.16M
-21.2%
Long Term Debt
$4.05M
-12.9%
Short Term Debt
$17.45M
+965.3%
Return on Assets
-1.30%
N/A
Return on Invested Capital
-1.66%
N/A
Free Cash Flow
$14.33M
+20.6%
Operating Cash Flow
$14.22M
+20.8%